AI-Rad Companion Brain MR

AI-Rad Companion Brain MR is an image analysis software tool designed to enhance radiological workflow by providing automated quantitative analysis of brain structures from MR images. It employs segmentation algorithms on T1 MPRAGE datasets and comparison with normative data from a healthy population to deliver volumetric assessments and visualizations, aiming to support clinicians in evaluating brain morphology.

AI-Rad Companion Brain MR is a post-processing image analysis software designed to assist clinicians in the viewing, analysis, and evaluation of magnetic resonance (MR) brain images. The system utilizes T1 MPRAGE datasets, typically acquired during standard head MR examinations, to perform automatic segmentation and quantitative analysis of 30 predefined individual brain structures, such as the hippocampus and caudate. It calculates both absolute and normalized volumetric properties for these structures, with normalization performed relative to the total intracranial volume. These patient-specific normalized values are then quantitatively compared against age-matched normative data derived from a healthy reference population, facilitating an objective assessment of brain structure volumes. The software presents its analytical results for reporting, including all numerical values and visualizations, which are directly archived in Picture Archiving and Communication Systems (PACS) for radiologist review. Key enhancements to the system, compared to its predicate, include a modified intended use statement, the addition of a customizable deviation map, and an architectural update for cloud-based deployment via the AI-Rad Companion Engine platform. The device's performance and functionality were validated through non-clinical tests, including software validation and bench testing, ensuring conformity with multiple industry standards for usability, risk management, software lifecycle, and digital imaging communications. Cybersecurity measures are also incorporated to protect data integrity and prevent unauthorized access.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the algorithm for automatic segmentation of the 30 brain structures account for anatomical variability and pathology-induced changes?; What is the composition and demographic diversity of the "healthy reference population" used for generating normative data, and how is its applicability ensured across different patient populations?; Can the "customizable deviation map" be tailored to highlight specific patterns of atrophy or volumetric change relevant to particular neurological conditions?; What are the specific performance metrics (e.g., Dice coefficient for segmentation, accuracy of volumetric measurements) achieved during non-clinical bench testing against ground truth data for the AI-Rad Companion Brain MR?; How does the cloud-based deployment architecture of the AI-Rad Companion Engine platform ensure data security and patient privacy, particularly when processing sensitive MR images?